SocGen Reinforces its Asia Cash Equity and Derivatives Businesses
Societe Generale Corporate & Investment Banking continues its expansion into the Asia Equity space, announcing a series of senior appointments across its trading desks aiming at increasing its servicing capacity in sales trading.
Akihiro Ohara has been appointed Head of Sales Trading for Japan. Akihiro joins from Nomura Securities where he occupied the same role for the last 7 years. Akihiro brings to the bank his wealth of experience and solid knowledge of the Japanese market. He will focus on servicing key Institutional accounts for all their trading needs. He will report to Masahiro Kubo, Head of Global Equities and Flow Derivatives Japan and both Matthew Perry and Sander Elzinga, Co-Heads of Cash Equities, Asia Pacific.
Lloyd Michaels has been appointed as Head of 1 Delta products Sales for Asia Pacific, based in Hong Kong. Lloyd has been in the industry for 14 years and has been working with Morgan Stanley, Merrill Lynch and UBS in diverse equity roles. His latest role was with BNPP where he was responsible for the build out of their new European Synthetic Hedge Fund sales trading effort. Lloyd will spearhead the development of the Delta 1 business with the aim to further market SG CIB’s capabilities to Hedge Funds, Asset Managers, proprietary trading desks and Mutual Funds in the region. He will report to Timothee Bousser, Head of Global Equities and Flow Derivatives, Asia Pacific.
Philip Cheung has been appointed as hybrid equity sales. He joins from Standard Chartered where he has been working for the past 5 years as hybrid equity sales and equity sales trader. Prior to that, Philip occupied similar positions at Bear Stearns and Goldman Sachs. His responsibilities will include expanding the Bank’s cash equity business and integrating the JIAsia research product. He will report to both Matthew Perry and Sander Elzinga.
The series of appointments are part of a wider plan by Societe Generale Corporate & Investment to further develop its Equities footprint in the region. In parallel to these appointments, the Bank’s equity business significantly improved its offering in the fields of Research and Execution this year, with the aim to provide one-stop-shop services to investors. Backed-up by a highly regarded Macro and bottom-up Research, the Bank is able to provide the full spectrum of Equity solutions in cash, derivatives and listed products, combined with state-of- the-art execution across 25 Asian exchanges.